Sort
16,179 grants matching “malaria”
After the flood: Optimal strategies to prevent malaria epidemics caused by severe flooding
$972,733Ross Mathew Boyce · Univ Of North Carolina Chapel Hill · R01 · FY2024 · AI
ICEMR-Mali : Multidisciplinary research for malaria control and prevention in West Africa
$972,562Seydou Doumbia · Univ Of Sciences, Tech & Tech Of Bamako · U19 · FY2019 · AI
Core-002
$971,739Kenneth D Stuart · Seattle Children'S Hospital · U19 · FY2025 · AI
Malaria Immunology and Pathogenesis in Pregnant Women and Young Children
$970,501Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Universal Attenuated Sporozoite Vaccine and Challenge System
$970,426Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2017 · AI
Mapping Drug Resistance Genes in Plasmodium falciparum
$970,185Tim J Anderson · Texas Biomedical Research Institute · R01 · FY2023 · AI
Malaria Drug Resistance and Disease Virulence
$970,119Thomas E Wellems · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Genomic and environmental risk factors for cardiometabolic disease in Africans
$970,000Michele Michele Ramsay · Wits Health Consortium (Pty), Ltd · U54 · FY2013 · HG
Defining the immunogenic landscape of early mosquito-stage P. falciparum to accelerate malaria transmission-blocking vaccine discovery
$969,948Kristian Edward Swearingen · Institute For Systems Biology · R01 · FY2024 · AI
MPOPHC: Quantitative design of effective testing-based policies through infection trajectory modeling
$968,765Stephen Kissler · University Of Colorado At Boulder · · FY2025 · MPS
A glycolipid adjuvant to promote dose sparing, accelerate immunization schedules and extend durability of high-level protection with an attenuated, live sporozoite malaria vaccine
$968,360Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2024 · AI
A glycolipid adjuvant to promote dose sparing, accelerate immunization schedules and extend durability of high-level protection with an attenuated, live sporozoite malaria vaccine
$968,151Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2023 · AI
Pregnancy Malaria Vaccine development
$967,251Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Pre-erythrocytic malaria vaccines: Discovery and Clinical Development
$967,251Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Cryopreservation of Anopheles Embryos
$966,818Peter F. Billingsley · Sanaria, Inc. · R44 · FY2022 · AI
Automating mosquito microdissection for a malaria PfSPZ vaccine
$966,428Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2022 · AI
Structural vaccinology for infectious diseases
$966,256Niraj Tolia · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Immune Deficient Mosquitoes for Improved Malaria Sporozoite Vaccine Manufacture
$966,108Peter F. Billingsley · Sanaria, Inc. · R44 · FY2019 · AI
In-Vitro Culture of Plasmodium falciparum Sporozoites for Malaria Vaccine
$965,661Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2021 · AI
Accelerating discovery of an efficacious Plasmodium vivax multivalent multi-stage vaccine
$965,047John Adams · University Of South Florida · U01 · FY2024 · AI
PfSPZ Vaccines: Quality Systems, Manufacturing, Regulatory, and Clinical Quality and Data Management Support for Product Commercialization
$965,038Stephen Lev Hoffman · Sanaria, Inc. · SB1 · FY2018 · AI
PANDAA for universal, pan-lineage molecular detection of filoviruses to enable rapid epidemic response.
$964,499Iain James Macleod · Aldatu Biosciences, Inc. · R44 · FY2022 · AI
India International Center for Excellence in Research
$963,448Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
LTQ Orbitrap Velos Mass Spectrometer System
$963,205Ruth Hogue Angeletti · Albert Einstein College Of Medicine · S10 · FY2010 · RR
Administrative Core
$962,858Matthew G Dorsey · University Of California, San Francisco · U19 · FY2021 · AI